Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder Psychedelics Investing
Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference Biotech Investing
Seelos Therapeutics Announces Dosing of the First Patients in a Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and Warrants Biotech Investing
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep Medical Device Investing
Pfizer's XALKORI® Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults Pharmaceutical Investing
Abbott to Launch the NeuroSphere myPath Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant Medical Device Investing
Medtronic Launches First-of-Its-Kind Adaptive Deep Brain Stimulation Trial in Parkinson's Disease Patients Medical Device Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
